SEARLE & CO. – Heron Therapeutics, Inc. Transaction History
SEARLE & CO. portfolio value:
$140,000
portfolio value
SEARLE & CO. quarter portfolio value change:
+51.25%
quarter
Heron Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 47K | $4.22 | 33.25K | |
| Q2 2022 | share | 0.00% | 0 shares | -97K | $2.79 | 33.25K | |
| Q1 2022 | share | Decrease | -30.37% | -14.5K shares | -246K | $5.72 | 33.25K |
| Q4 2021 | share | 0.00% | 0 shares | -74K | $9.31 | 47.75K | |
| Q3 2021 | share | Increase | +1.06% | 500 shares | -223K | $10.69 | 47.75K |
| Q2 2021 | share | Increase | +26.85% | 10K shares | 129K | $15.52 | 47.25K |
| Q1 2021 | share | Decrease | -1.32% | -500 shares | -195K | $16.21 | 37.25K |
| Q4 2020 | share | Decrease | -1.95% | -750 shares | 228K | $21.17 | 37.75K |
| Q3 2020 | share | Increase | +32.76% | 9.5K shares | 144K | $14.82 | 38.5K |
| Q2 2020 | share | Decrease | -1.69% | -500 shares | 81K | $14.71 | 29K |
| Q1 2020 | share | Increase | +136.00% | 17K shares | 52K | $11.74 | 29.5K |
| Q4 2019 | share | Increase | +13.64% | 1.5K shares | 90K | $23.5 | 12.5K |
| Q3 2019 | share | Decrease | -47.99% | -10.15K shares | -189K | $18.5 | 11K |
| Q2 2019 | share | Increase | 0.00% | 21.15K shares | 393K | $18.59 | 21.15K |
| Q3 2017 | share | Decrease | -100.00% | -26.5K shares | -367K | $16.15 | 0 |
| Q2 2017 | share | Increase | +12.77% | 3K shares | 14K | $13.85 | 26.5K |
| Q1 2017 | share | Increase | 0.00% | 23.5K shares | 353K | $15 | 23.5K |